Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/29/1998US5854016 Creba Isoform
12/29/1998US5854015 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
12/29/1998US5853987 Decorin binding protein compositions and methods of use
12/29/1998US5853976 Recombinant proteinase from clostridium histolyticum and its use for isolating cells and groups of cells
12/29/1998US5853763 Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release
12/29/1998US5853759 Effervescent alendronate formulation
12/29/1998US5853756 Controlled release formulations of Ranitidine
12/29/1998US5853748 Pharmaceutical compositions
12/29/1998US5853742 Cosmetic compositions containing lactate dehydrogenase inhibitors
12/29/1998US5853732 Pharmaceutical compositions containing kukui nut oil
12/29/1998US5853723 Targeting of peg antibody conjugates to islet cells
12/29/1998US5853719 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
12/29/1998US5853703 Preventing and reversing the formation of advanced glycosylation endproducts
12/29/1998US5853699 Use of tetra azacycle complexes as x-ray diagnostic agents for the liver and gallbladder
12/29/1998US5853697 Methods of treating established colitis using antibodies against IL-12
12/29/1998US5853695 Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions
12/29/1998US5853616 Method for preparing low-concentration polyaluminosilicate microgels
12/29/1998US5853003 Treatment and diagnosis of respiratory disorders using fluorocarbon liquids
12/29/1998CA2171281C Immunomodulating compositions from bile
12/29/1998CA2158583C Pharmaceutical composition in the form of a kit
12/29/1998CA2153050C Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
12/29/1998CA2152817C Novel pyridone carboxylic acid derivatives
12/29/1998CA2135203C Metering spray designed for pernasal application
12/29/1998CA2109415C Substituted 3-aminoquinuclidines
12/29/1998CA2045478C Xanthine compounds
12/29/1998CA2036427C Acyl compounds
12/29/1998CA2017692C Carboxamide derivatives
12/29/1998CA2002859C Method of treating epithelial disorders
12/29/1998CA1340291C Oxaspiro ¬2,5| octane derivative
12/27/1998CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/27/1998CA2209222A1 Retrovirus protease inhibitors
12/26/1998CA2235778A1 Novel glmu
12/24/1998DE19736198C1 Protease related protein
12/24/1998DE19726427A1 Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel Pyrimidine-2,4,6-trione derivatives, processes for their preparation and medicaments containing these compounds
12/24/1998DE19725799A1 Use of substituted thio-phenoxy derivatives
12/24/1998DE19725664A1 3-Benzylpiperidine 3 Benzylpiperidine
12/24/1998DE19725615A1 Zur topischen Applikation bestimmte Diclofenac-Lösung For topical application specific diclofenac solution
12/24/1998DE19725405A1 Physiologische Wirkstoffkombination zur Förderung der Abwehrleistung der Haut gegenüber Noxen Physiological drug combination to promote the defense capacity of the skin to noxious
12/24/1998DE19725186A1 Herz- und Skelettmuskel-spezifische Nukleinsäure, ihre Herstellung und Verwendung Heart and skeletal muscle-specific nucleic acid, their preparation and use
12/24/1998DE19724696A1 Pharmazeutische Zubereitung mit drei Pelletarten Pharmaceutical composition with three pellet types
12/24/1998DE19724444A1 Transdermal composition, especially for vitamin=A, C and E application
12/24/1998DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998058058A1 Hammerhead ribozymes with extended cleavage rule
12/23/1998WO1998058010A1 Polymer comprising unsaturated ester units and pharmaceutical and cosmetic compositions thereof
12/23/1998WO1998057980A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057972A1 Quaternary ammonium compounds as tachykinin antagonists
12/23/1998WO1998057970A1 Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
12/23/1998WO1998057969A1 4-haloalkyl-3- heterocyclylpyridines and 4-haloalkyl -5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
12/23/1998WO1998057968A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
12/23/1998WO1998057967A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same
12/23/1998WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998WO1998057965A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
12/23/1998WO1998057963A1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
12/23/1998WO1998057962A1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
12/23/1998WO1998057961A1 Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/23/1998WO1998057960A1 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/23/1998WO1998057959A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
12/23/1998WO1998057955A1 Compounds useful for inhibition of farnesyl protein transferase
12/23/1998WO1998057954A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/23/1998WO1998057953A1 3-benzylpiperidine
12/23/1998WO1998057951A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
12/23/1998WO1998057950A1 Novel phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
12/23/1998WO1998057949A1 Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase
12/23/1998WO1998057948A1 Novel n-substituted urea inhibitors of farnesyl-protein transferase
12/23/1998WO1998057947A1 Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors
12/23/1998WO1998057946A1 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
12/23/1998WO1998057945A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors
12/23/1998WO1998057944A1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
12/23/1998WO1998057942A1 9-oxa prostaglandin analogs as ocular hypotensives
12/23/1998WO1998057941A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
12/23/1998WO1998057940A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998WO1998057939A1 Crystalline roxifiban
12/23/1998WO1998057937A2 Inhibitors of factor xa with a neutral p1 specificity group
12/23/1998WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998WO1998057932A1 New amidino derivatives and their use as thrombin inhibitors
12/23/1998WO1998057931A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto
12/23/1998WO1998057930A1 Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
12/23/1998WO1998057927A1 Elevation of hdl cholesterol by 4-[(aminothioxomethyl)hydrazono]-4-arylbutyl carbamates
12/23/1998WO1998057919A1 Selective thyroid hormone analogs
12/23/1998WO1998057917A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS
12/23/1998WO1998057668A1 Diagnostic agents and remedies for malignant tumors
12/23/1998WO1998057662A2 Therapeutic systems
12/23/1998WO1998057656A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
12/23/1998WO1998057654A1 Methods for treatment of ocular neovascularization
12/23/1998WO1998057652A1 Polyallylamine polymers for treating hypercholesterolemia
12/23/1998WO1998057651A1 Compositions and methods for preventing restenosis following revascularization procedures
12/23/1998WO1998057649A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
12/23/1998WO1998057648A1 Methods of increasing the bioavailability of stable crystal polymorphs of a compound
12/23/1998WO1998057647A1 Coup-tfii: an orphan nuclear receptor required for angiogenesis
12/23/1998WO1998057645A1 Hepatic edema remedy
12/23/1998WO1998057644A1 Preventive and remedy for drug-induced nephropathy
12/23/1998WO1998057643A1 Use of draflazine-analogues for treating pain
12/23/1998WO1998057642A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057641A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057640A1 Alpha 1a adrenergic receptor antagonists
12/23/1998WO1998057639A1 ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057638A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057637A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
12/23/1998WO1998057636A1 Treatment of diabetes with rosiglitazone and insulin
1 ... 6561 6562 6563 6564 6565 6566 6567 6568 6569 6570 6571 6572 6573 6574 6575 6576 6577 6578 6579 6580 6581 ... 7860